搜尋結果
Lung Cancer Is Personal: Interview With Lee James
ACCESSWIRE· 1 年前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Bristol Myers Squibb Company non-small cell ...
Why Clinical Trial Diversity Is So Important - and What the Healthcare Sector Can Do
ACCESSWIRE· 1 年前Physicians prescribe medication and design treatment and therapy plans for their patients based ...
Can Genomics Stop the World's Leading Cause of Death?
ACCESSWIRE· 1 年前For decades, cardiovascular disease has remained the number-one cause of death. In 2019 alone, ...
12 Employee Benefits That Make Boston Scientific a "Best Place To Work"
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / October 26, 2022 / Boston Scientific At Boston Scientific, our ...
康霈明年IMCAS醫美大會 將發表局部減脂新藥2期臨床數據
三立新聞網 setn.com via Yahoo奇摩新聞· 4 個月前記者王翊綺/台北報導 康霈生技(6919)將於明(2024)年2月巴黎舉辦的25屆IMCAS世界醫學美容大會上, ...
信達生物 IBI311(抗IGF-1R抗體)臨床I期研究完成首例給葯
PR Newswire Asia· 2 年前美國三藩市和中國蘇州2022年8月18日 /美通社/ -- 信達生物製藥集團(香港聯交所股票代碼:01801),一家致力於研發、生產和銷售腫瘤、自免、代謝、眼科等重 ...